About us

Viroimmun Biotechnology was established in 2022 at Entertech Istanbul Teknokent, under the support of the Scientific and Technological Research Council of Turkey (TUBITAK), 1512-Entrepreneurship Support Program. Viroimmun Biotechnology is an innovative biotechnology company that aims to combine the science disciplines of virology and immunology with technology in order to protect and improve human, animal and community health.

The control of chronic diseases and cancer diseases, which are associated with outbreak caused by viruses, can be achieved with the development of antiviral immunity. Ultimately, the existence of a balance between viruses and the immune system is critical for the protection and sustainability of health at the individual and societal level. Today, biotechnology occupancy important place in the development of antiviral and immunotherapeutic drugs, vaccines and laboratory diagnostic systems. Viroimmun Biotechnology aims at the research and synthesis of biological products for the diagnosis and treatment and prevention of viral and immunological diseases, based on the specific interaction between immunogen and immunity, antigen and antibody.

Also; Viroimmun Biotechnology focuses on the control and management of disinfection and sterilization processes, which are critical in the control and prevention of hospital-acquired infections, and on the production of biotechnological solutions for the provision and development of sterilisation barrier systems and medical packaging.